Emerging strategies in the treatment of testis cancer.
The state of the art in the study and therapy of germ-cell tumors of the testis is reflected in this year's literature. For the majority of patients with germ-cell tumors, the therapeutic dilemma no longer relates to cure. For such patients with low-volume non-seminomatous germ-cell tumors of the testicle and those with a pure seminoma, therapeutic dilemmas relate more to selection of the appropriate therapy to achieve cure, the toxicity of therapy, and the precise prediction of outcome. However, a high cure rate cannot be anticipated with equal frequency in those patients with high-volume non-seminomatous germ-cell tumors of the testicle.